Transforming healthcare through in-body bioelectronic systems

Recent advances in the development of in-body bioelectronic systems are providing new opportunities for the clinical management of various diseases and disorders. These emerging technologies are tailored to specific organs and are beginning to blend both diagnostic sensing and therapeutic actuation. The aim of these systems is to seamlessly integrate with the physiological environment, as illustrated by the diverse device strategies discussed throughout this article. Next generation modalities, such as optogenetics combining gene therapy with devices for photostimulation, are gaining popularity and offer advantages over existing therapeutic strategies. In this perspective, we explore the current state of technological developments, key challenges in the field and potential pathways for translating these innovations into clinical practice.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2026-04-11
DOI
https://doi.org/10.1038/s41467-026-71188-3
Primary Topic
Photoreceptor and optogenetics research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Transforming healthcare through in-body bioelectronic systems

Ivan R. Minev, Michalina J. Gora, Shriya S. Srinivasan, Thomas H. Hutson et al.
Nature Communications
Photoreceptor and optogenetics research
article

Transforming healthcare through in-body bioelectronic systems

Ivan R. Minev, Michalina J. Gora, Shriya S. Srinivasan, Thomas H. Hutson, Claudia Kathe, John A. Rogers, Khalil B. Ramadi, Christoph Tondera, Steven Ceto, Kyuhwa Lee, Mingzheng Wu, Stacey Amanda Elshove
article en

Abstract

Recent advances in the development of in-body bioelectronic systems are providing new opportunities for the clinical management of various diseases and disorders. These emerging technologies are tailored to specific organs and are beginning to blend both diagnostic sensing and therapeutic actuation. The aim of these systems is to seamlessly integrate with the physiological environment, as illustrated by the diverse device strategies discussed throughout this article. Next generation modalities, such as optogenetics combining gene therapy with devices for photostimulation, are gaining popularity and offer advantages over existing therapeutic strategies. In this perspective, we explore the current state of technological developments, key challenges in the field and potential pathways for translating these innovations into clinical practice.

Nature CommunicationsVol. 17(1)
Northwestern University (US), Brigham and Women's Hospital (US), Centre National de la Recherche Scientifique (FR), Harvard University (US), Leibniz Institute of Polymer Research (DE), Wyss Center for Bio and Neuroengineering (CH), University Hospital Carl Gustav Carus (DE), New York University (US), Massachusetts Institute of Technology (US), Université de Strasbourg (FR), Technische Universität Dresden (DE), University of Lausanne (CH)
National Science Foundation, Novartis Foundation, European Commission, International Foundation for Research in Paraplegia, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Innosuisse - Schweizerische Agentur für Innovationsförderung, Horizon 2020 Framework Programme
Industry, innovation and infrastructure
Openalex Percentile: Top 26%
Photoreceptor and optogenetics research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.